Dick Stockelberg, Södra Älvsborgs sjukhus (SÄS) workplace verified by Västra Götalandsregionen on 2018-02-27

Basic information

name:
Dick Stockelberg
profession:
Läkare
email:

Work

department:
Medicinkliniken, Södra Älvsborgs sjukhus
workplace:
Medicinkliniken SÄS
phone number:
0704-509552
city:
51280 Borås
country:
Sverige

Doctoral Thesis (1)

Article - Review (1)

  1. Acta Paediatr Suppl 1998:424:26-36.
    Web of Science® citations 13

Article - Peer reviewed scientific (70)

  1. Mosrati MA, Willander K, Falk IJ, Hermanson M, Höglund M, Stockelberg D, Wei Y, Lotfi K, Söderkvist P.
    Oncotarget 2015:6(28):25109-20.
    Web of Science® citations 20
  2. Lazarevic V, Hörstedt A-S, Johansson B, Antunovic P, Billström R, Derolf Å, Lehmann S, Möllgård L, Peterson S, Stockelberg D, Uggla B, Vennström L, Wahlin A, Höglund M, Juliusson G.
    Eur J Haematol 2015:94(5):419-423.
    Web of Science® citations 3
  3. Wennström L, Edslev P, Abrahamsson J, Nørgaard J, Fløisand Y, Forestier E, Gustafsson G, Heldrup J, Hovi L, Jahnukainen K, Jonsson O, Lausen B, Palle J, Zeller B, Holmberg E, Juliusson G, Stockelberg D, Hasle H.
    Pediatric blood & cancer 2015
    Web of Science® citations 6
  4. Hulegårdh E, Nilsson C, Lazarevic V, Garelius H, Antunovic P, Derolf AR, Möllgård L, Uggla B, Wennström L, Wahlin A, Höglund M, Juliusson G, Stockelberg D, Lehmann S.
    Am J Hematol. 2014
    Web of Science® citations 30
  5. Lazarevic V, Horstedt A, Johansson B, Antunovic P, Billstrom R, Derolf A, Hulegardh E, Lehmann S, Mollgard L, Nilsson C, Peterson S, Stockelberg D, Uggla B, Wennstrom L, Wahlin A, Hoglund M, Juliusson G, Hörstedt A, Johansson E, Billström R, Hulegårdh E, Möllgård L, Wennström L, Höglund M.
    Blood Cancer J 2014:4(Feb 28):e188-.
    Web of Science® citations 24
  6. Högberg K, Sandman L, Nyström M, Stockelberg D, Broström A.
    Eur J Oncol Nurs 2013:17(5):596-602.
    Web of Science® citations 6
  7. Skovbjerg S, Welinder-Olsson C, Kondori N, Kjellin E, Nowrouzian F, Wold A, Stockelberg D, Larsson P, Wennerås C.
    Clin Microbiol Infect. 2009:15(7):680-3.
    Web of Science® citations 12
  8. Johansson JE, Hasséus B, Johansson P, Eklöf C, Ohman D, Stockelberg D.
    Bone Marrow Transplant. 2009:43(10):807-11.
    Web of Science® citations 8
  9. [Specialist associations' mission: equal and good cancer care for all].
    [Specialistföreningarnas uppdrag: likvärdig och god cancervård för alla.]
    Linderholm M, Höglund M, Stockelberg D.
    Lakartidningen 2008:105(5):306-7.
  10. Linderholm M, Höglund M, Stockelberg D.
    Lakartidningen 2008:105(5):306-7.
  11. Cornely OA, Maertens J, Winston DJ, Perfect J, Ullmann AJ, Walsh TJ, Helfgott D, Holowiecki J, Stockelberg D, Goh YT, Petrini M, Hardalo C, Suresh R, Angulo-Gonzalez D.
    N Engl J Med. 2007:356(4):348-59.
    Web of Science® citations 862
  12. Juliusson G, Billström R, Gruber A, Hellström-Lindberg E, Höglunds M, Karlsson K, Stockelberg D, Wahlin A, Aström M, Arnesson C, Brunell-Abrahamsson U, Carstensen J, Fredriksson E, Holmberg E, Nordenskjöld K, Wiklund F;
    Swedish Adult Acute Leukemia Registry Group.
    Leukemia 2006:20(1):42-7.
    Web of Science® citations 48
  13. Wei Y, Hezaveh R, Olsson B, Ricksten A, Palmqvist L, Stockelberg D, Wadenvik H.
    Haematologica 2006:91(suppl 1):249.
  14. Hallböök H, Hägglund H, Stockelberg D, Nilsson PG, Karlsson K, Björkholm M, Linderholm M, Wahlin A, Linder O, Smedmyr B;
    Swedish Adult ALL Group.
    Bone Marrow Transplant. 2005:35(12):1141-8.
    Web of Science® citations 11
  15. Lofgren C, Paul C, Astrom M, Hast R, Hedenius M, Lerner R, Liliemark J, Nilsson I, Rodjer S, Simonsson B, Stockelberg D, Tidefelt U, Bjorkholm M.
    Br J Haematol 2004:124:474.
    Web of Science® citations 23
  16. [CPP (Cost Per Patient) is functioning well in the everyday care. The myeloma care program in Vastra Gotaland--an illustrative example].
    [KPP (Kostnad Per Patient) fungerar utmärkt i vårdens vardag. Myelomvårdprogram i Västra Götaland--ett illustrativt exempel.]
    Stockelberg D, Heurgren M, Sjöli P, Väärt J, Mellqvist UH, Kron B.
    Lakartidningen 2003:100(42):3316-8.
  17. Hallböök M, Hagglund M, Sallerfors B, Ahlgren T, Billstrom R, Björkholm M, Markevarn B, Nilsson B, Simonsson B, Stockelberg D, Wahlin A.
    Bone Marrow Transplant 2003:32:1119.
    Web of Science® citations 2
  18. Stockelberg DS, Heurgren MH, Kron BK, Sjöli PS, Väärt JV, Mellqvist UHM.
    Läkartidningen 2003:100(42):3316-3318.
  19. Wernstedt P, Brune M, Andersson P, Gustavsson B, Stockelberg D, Wadenvik H.
    Bone Marrow Transplant. 2002:30(12):971-3.
    Web of Science® citations 2
  20. Hallböök H, Simonsson B, Ahlgren T, Björkholm M, Carneskog J, Grimfors G, Hast R, Karlsson K, Kimby E, Lerner R, Linder O, Linderholm M, Löfvenberg E, Malm C, Nilsson PG, Paul C, Stenke L, Stockelberg D, Tidefelt U, Turesson I, Uden-Blome AM, Vilen L, Wahlin A, Winquist I, Smedmyr B.
    Br J Haematol. 2002:118(3):748-54.
    Web of Science® citations 34
  21. Hallbook H, Simonsson B, Ahlgren T, Bjorkholm M, Carneskog J, Grimfors G, Hast R, Karlsson K, Kimby E, Lerner R, Linder O, Linderholm M, Lofvenberg E, Malm C, Nilsson P, Paul C, Stenke L, Stockelberg D, Tidefelt U, Turesson I, Uden-Blome A, Vilen L, Wahlin A, Winquist I, Smedmyr B.
    Br J Haematol 2002:118:748.
    Web of Science® citations 34
  22. Sjöblom L, Hårdemark HG, Lindgren A, Norrving B, Fahlén M, Samuelsson M, Stigendal L, Stockelberg D, Taghavi A, Wallrup L, Wallvik J.
    Stroke 2001:32(11):2567-74.
    Web of Science® citations 151
  23. Andreasson B, Lindstedt G, Stockelberg D, Wadenvik H, Kutti J.
    Leukemia & lymphoma 2001:41(5-6):579-84.
    Web of Science® citations 4
  24. Stockelberg D, Andersson P, Björnsson E, Björk S, Wadenvik H.
    J Intern Med. 1999:246(5):471-5.
    Web of Science® citations 21
  25. [Survey of complications following treatment with anticoagulants. A computerized search for hemorrhagic complications completes manual reporting].
    [Kartläggning av komplikationer vid antikoagulantiabehandling. Automatiserat sök efter blödningar kompletterar manuell rapportering.]
    Taghavi A, Jonson T, Stockelberg D.
    Lakartidningen 1999:96(32-33):3421-4.
  26. [Nurses working with anticoagulants--a new subspecialty? Time for a new and important kind of training]
    [Antikoagulantiasköterska--en ny subspecialitet? Hög tid för en ny och viktig utbildning.]
    Stockelberg D, Stigendal L, Eriksson H.
    Lakartidningen 1999:96(10):1205-7.
  27. Eriksson H, Eriksson UG, Frison L, Hansson PO, Held P, Holmström M, Hägg A, Jonsson T, Lapidus L, Leijd B, Stockelberg D, Säfwenberg U, Taghavi A, Thorsén M.
    Thromb Haemost. 1999:81(3):358-63.
    Web of Science® citations 89
  28. Johansson P, Stockelberg D, Ekman T, Ridell B.
    Annals of Oncology 1999:10(Suppl. 3)
  29. Stockelberg D, Hansson E, Jonson T.
    J Thromb Thrombolysis 1998:6(2):169-171.
    Web of Science® citations 4
  30. Stockelberg D, Lehtola P, Norén I.
    Support Care Cancer 1997:5(6):506-8.
    Web of Science® citations 20
  31. Hou M, Stockelberg D, Kutti J, Wadenvik H.
    Thromb Haemost. 1996:75(4):642-7.
    Web of Science® citations 3
  32. Hou M, Stockelberg D, Kutti J, Wadenvik H.
    Br J Haematol. 1995:91(4):971-5.
    Web of Science® citations 14
  33. [Home care of deep venous thrombosis].
    [Behandling i hemmet av djup ventrombos.]
    Stockelberg D, Hansson E, Andersson I, Rystrdöm B.
    Lakartidningen 1995:92(34):3014-5.
  34. Carlsson H, Stockelberg D, Tengborn L, Braide I, Carneskog J, Kutti J.
    Eur J Haematol. 1995:55(5):289-93.
    Web of Science® citations 29

Conference Paper - Peer reviewed (17)

  1. Proportion of Adult AML Patient Population Receiving Allogeneic Stem Cell Transplantation and Long-Term Outcome:.
    [Real World Data From the Swedish National Acute Leukemia Registry. in BLOOD, vol 114, issue 22, pp 903-903]
    Juliusson G, Mollgard L, Lehmann S, Derolf A, Tidefelt U, Stockelberg D, Brune M, Lazarevic V, Antunovic P, Wahlin A, Hoglund M.
    American Society of Hematology; 2009.
  2. Juliusson G, Billström R, Gruber A, Hellström-Lindberg E, Höglund M, Karlsson K, Stockelberg D, Wahlin A, Åström M, Arnesson C, Holmberg E, Nordenskjöld K, Carstensen J.
    Geneva: European Hematology Association; 2004.
  3. Wei Y, Stockelberg D, Ricksten A, Wadenvik H.
    Aarhus, Denmark: The Nordic Hematology Spring Meeting; 2004.
  4. Juliusson G, Billström R, Gruber A, Hellström-Lindberg E, Höglund M, Karlsson K, Stockelberg D, Wahlin A, Åström M.
    San Diego: American Society of Hematology; 2003.
  5. Hardling M, Ricksten A, Swolin B, Palmqvist L, Gustavsson B, Stockelberg D, Wadenvik H.
    Reykjavik, Iceland: The Nordic Hematology Spring Meeting; 2003.
  6. Wennström L, Juntikka E.L, Safai-Kutti S, Stockelberg D, Holmberg E, Luik E, Everaus H, Palk K, Varik M, Aareleid T, Kutti J.
    Florence, Italy, June: European Hematology Association; 2002.
  7. Luik E, Palk K, Varik M, Everaus H, Aareleid T, Wennström L, Juntikka E.L, Safai-Kutti S, Stockelberg D, Kutti J, Holmberg E.
    Florence, Italy, June: European Hematology Association; 2002.
  8. Höglund M, Brune M, Sallerfors B, Billström R, Markevärn B, Simonsson B, Stockelberg D, Wahlin A.
    Göteborg: Svenska Läkaresällskapets Riksstämma; 2000.
  9. Andersson PO, Stockelberg D, Jacobsson S, Jacobsson S, Wadenvik H.
    New Orleans, USA: 41th Annual Meeting for the American Society of Hematology; 1999.
  10. Andersson PO, Stockelberg D, Jacobsson S, Wadenvik H.
    Barcelona, Spain: 4th meeting of the European Haematology Association; 1999.
  11. Göteborg: Svenska Läkaresällskapets Riksstämma; 1998.
  12. Andersson PO, Stockelberg D, Hou M, Wadenvik H.
    Stockholm: Svenska Läkaresällskapets Riksstämma; 1997.
  13. Wadenvik H, Hou M, Stockelberg D, Kutti J.
    Florence, Italy: XVIth Congress of the International Society on Thrombosis and Haemostasis; 1997.
  14. Hou M, Horney E, Lagerstedt C, Jacobsson S, Stockelberg D, Kutti J, Wadenvik H.
    Paris, France: 2nd Meeting of the European Haematology Association; 1996.
  15. Hou M, Stockelberg D, Kutti J, Wadenvik H.
    Tromsö, Norway: The Nordic Hematology Spring Meeting; 1995.
  16. Stockelberg D, Jacobsson S, Hou M, Swolin B, Kutti J, Wadenvik H.
    Stockholm: Svenska Läkaresällskapets Riksstämma; 1994.

Conference Poster (35)

  1. Sören EH, Lazarevis V, Hörstedt A, Hulegårdh E, Nilsson C, Hulegårdh EH, Derolf Å, Uggla B, Vennström L, Wahlin A, Höglund M, Stockelberg D, Juliusson G, al E.
    American Society of hematology, USA: ASH 2012; 2012.
  2. Lehmann EH, Hulegårdh E, Lazarevis V, Hörstedt A, Hulegårdh E, Nilsson C, Antunovic P, Derolf Å, Uggla B, Vennström L, Wahlin A, Höglund M, Stockelberg D, Juliusson G.
    American Society of hematology, USA: ASH 2012; 2012.
  3. Juliusson G, Billstrom R, Gruber A, Hellstrom-Lindberg E, Hoglund M, Karlsson K, Stockelberg D, Wahlin A, Astrom M.
    BLOOD; 2003.
  4. Hallböök H, Hägglund H, Karlsson K, Linder O, Linderholm M, Nilsson PG, Stockelberg D, Turesson I, Wahlin A, Svedmyr B.
    Lyon: European Hematology Association; 2003.
  5. Löfgren C, Pau C, Åström M, Has R, Hedenius M, Lerne R, Liliemark J, Nilsson I, Rödjer S, Simonsson B, Stockelberg D, Tidefelt U, Björkholm M.
    Linköping: NHSM; 2002.
  6. Wernstedt P, Stockelberg D, Johansson JE, Brune M.
    Philadelphia: American Society of Hematology; 2002.
  7. Ricksten A, Palmqvist L, Swolin B, Hardling M, Stockelberg D, Gustavsson B, Wadenvik H.
    Florence: European Hematology Association; 2002.
  8. Heurgren M, Felt M, Dannberg E, Kron B, Netzler B, Sjöli P, Stockelberg D, Väärt J.
    Brugge: 17:th Internatoional Working Conference on Patient Classification System/Europe (PCS/E); 2001.
  9. Bram S, Rodjer S, Stockelberg D, Ogard I, Back H, Swolin B.
    Stockholm: Nordic MDS Group; 2001.
  10. Johansson P, Ekman T, Ridell B, Stockelberg D.
    Barcelona: E H A | European Hematology Association; 1999.
  11. Olsson A, Stockelberg D, Andersson PO, Kutti J, Wadenvik H.
    Amsterdam: European Association of Hematology; 1998.
  12. Andersson PO, Hou M, Stockelberg D, Kutti J, Wadenvik H.
    Amsterdam: European Association of Hematology; 1998.
  13. Kecskes M, Stockelberg D, Grip L, Kutti J, Wadenvik H.
    Miami: American Society of Hematology; 1998.
  14. Stockelberg D, Jonsson T, Hansson E.
    Florence: International Society of Thrombosis and Hemostasis; 1997.
  15. Stockelberg D, Jacobsson S, Kutti J, Wadenvik H.
    Uppsala: Nordiskt hematologiskt vårmöte; 1996.
  16. Hou M, Stockelberg D, Rydberg L, Kutti J, Wadenvik H.
    Hämeenlinna: 4:th European syposium on platelet and granulocyte immunobiology; 1996.
  17. Wadenvik H, Hou M, Horney E, Lagerstedt C, Jacobsson S, Stockelberg D, Kutti J.
    Hämeenlinna: 4:th European syposium on platelet and granulocyte immunobiology; 1996.
  18. Stockelberg D, Jonsson T.
    Paris: European Association of Hematology; 1996.
  19. Hou M, Stockelberg D, Rydberg L, Kutti J, Wadenvik H.
    Paris: European Association of Hematology; 1996.
  20. Wadenvik H, Hou M, Horney E, Lagerstedt C, Jacobsson S, Stockelberg D, Kutti J.
    Paris: European Association of Hematology; 1996.
  21. Norén I, Lethola P, Stockelberg D.
    Helsingfors: Nordiskt Hematologiskt Vårmöte; 1996.
  22. Jonsson T, Andersson I, Rydström B, Stockelberg D.
    Stockholm: Svenska Läkaresällskapets Riksstämma; 1995.
  23. Hou M, Wadenvik H, Stockelberg D, Andersson I, Kutti J.
    Bryssel: European Association of Hematology; 1994.
  24. Stockelberg D, Jacobsson S, Hou M, Swolin B, Kutti J, Wadenvik H.
    Nashville: American Society of Hematology; 1994.
  25. New York: International Society of Thrombosis and Hemostasis; 1993.

Conference Paper - Other (3)

  1. Andersson PO, Olsson A, Stockelberg D, Wadenvik H.
    San Fransisco: American Society of Hematology; 2000.
  2. Stockholm: Symposium, Fragmin 10-årsjubileum; 1998.

Article - Other scientific (5)

  1. [Pascal turns one--time for the next step].
    [Pascal fyller ett år--dags för nästa steg.]
    Lakartidningen 2013:110(27-28):1295-6.
  2. Poor Outcome in Secondary Acute Myeloid Leukemia (AML).
    [A First Report From the Population-Based Swedish Acute Leukemia Registry]
    Lehmann S, Lazarevic V, Horstedt A, Hulegardh E, Nilsson C, Antunovic P, Derolf A, Mollgard L, Uggla B, Vennstrom L, Wahlin A, Höglund M, Stockelberg D, Juliusson G, Hörstedt A, Hulegårdh E, Derolf Å, Möllgård L, Vennström L.
    Blood 2012:120(21)
    Web of Science® citations 1
  3. Heurgren M, Felt M, Dannberg E, Netzler B, Stockelberg D, Kron B, Sjöli P, Väärt J.
    Case Mix 2002:31:3-10.

Other (2)

  1. Juliusson G, Wahlin A, Stockelberg D, Mollgard L, Brune M, Antunovic P, Lehmann S, Tidefelt U, Lazarevic V, Derolf A, Hoglund M.
    Bone Marrow Transplant. 2010:45:S9-S10.
  2. Juliusson G, Mollgard L, Lehmann S, Derolf A, Tidefelt U, Stockelberg D, Brune M, Lazarevic V, Antunovic P, Wahlin A, Hoglund M.
    Blood 2009:114(22):903.

Scientific publications

1. Forsberg B, Jacobsson S, Stockelberg D, Kutti J, Rydberg L, and Hans Wadenvik. The platelet specific alloantigen PLA1 (HPA-1a). A comparison between flow cytometry immunophenotyping and genotyping using PCR-RFLP in a Swedish blood donor population. Transfusion 1995: 35: 241-246

2. Stockelberg D, Jacobsson S, Kutti J, Wadenvik H. Evidence for a light chain restriction of Glycoprotein Ib/IX and Glycoprotein IIb/IIIa reactive autoantibodies in chronic immune thrombocytopenic purpura (ITP) Br J Haematol 1995: 90: 175-179

3. Stockelberg D, Hansson E, Andersson I, Rydström B. Poliklinisk behandling av djup ventrombos med lågmolekylärt heparin (Fragmin). Läkartidningen 1995: 92: 3014-3015

4. Hou M, Stockelberg D, Kutti J, Wadenvik H. Antibodies against platelet GPIb/IX, GPIIb/IIIa and other platelet antigens in chronic immune thrombocytopenic purpura. Eur J Haematol: 1995: 55: 307-314

5. Hou M, Stockelberg D, Kutti J, Wadenvik H. Fab-mediated binding of glycoprotein Ib/IX and IIb/IIIa specific antibodies in chronic immune thrombocytopenic purpura. Br J Haematol: 1995: 91: 944-950

6. Stockelberg D, Hou M, Jacobsson S, Kutti J, Wadenvik H. Light chain restricted autoantibodies in chronic ITP but no evidence for circulating clonal B-lymphocytes. Ann of Haematol 1996: 72: 29-34

7. Stockelberg D, Jacobsson S, Kutti J, Wadenvik H. Detection of platelet antibodies in chronic immune thrombocytopenic purpura (ITP). A comparative study using flow cytometry, whole platelet ELISA and an antigen capture ELISA. Eur J Haematol 1996: 56: 72-77

8. Carlsson H, Stockelberg D, Tengborn L, Braide I, Carneskog J, Kutti J. Effects of Erwinia-asparaginase on the coagulation system. Eur J Haematol 1996: 55: 289-293

9. Hou M, Stockelberg D, Kutti J, Wadenvik H. Glycoprotein IIb/IIIa autoantigenic repertoire in chronic idiopathic thrombocytopenic purpura (ITP). Br J Haematol 1995: 91: 971-975

10. Ming Hou, Dick Stockelberg, Jack Kutti and Hans Wadenvik. Naturally occurring IgG
autoantibodies to platelet cytoskeleton tropomyosin. Thrombosis and Haemostasis 1996; 75: 642-647

11. Stockelberg D, Hou M, Rydberg L, Kutti J, Wadenvik H. Evidence for an expression of blood group A antigen on platelet glycoproteins IV and V. Transfusion Medicine 1996: 6: 243-248

12. Hou M, Stockelberg D, Rydberg L, Kutti J, Wadenvik H. Blood group A antigen expression in platelets is prominently associated with glycoprotein Ib and IIb. Evidence for an A1/A2 difference. Transfusion Medicin 1996: 6 : 51-59.

13. Stockelberg Dick. Some properties of platelet antibodies. With special reference to the autoantibodies in chronic idiopathic thrombocytopenic purpura. Thesis 1996, Gothenburg University

14. Hou M, Stockelberg D, Kutti J, Wadenvik H. Immunoglobulins targeting at both GPIIb/IIIa and GPIb/IX in chronic idiotathic thrombocytopenic purpura (ITP) is mediated by at least two IgG antibodies. Br J Haematol, 1997: 98: 64-67

15. Hou M, Horney E, Lagerstedt C, Jacobsson S, Stockelberg D, Kutti J, Wadenvik H. Multiple quinine-dependent antibodies in a patient with episodic thrombocytopenia, neutropenia, lymphopenia, and granulomatous hepatatis. Blood, 1997: 90: 4806-4811

16. Stockelberg D, Norén I, Lethola P. Palliative treatment at home for patients with hematological disorders. Support Care Cancer. 1997 Nov; 5(6): 506-508.

17. Hou M, Andersson PO, Stockelberg D, Mellqvist UH, Ridell B, Wadenvik H Plasma thrombopoietin levels in thrombocytopenic states: implication for a regulatory role of bone marrow megakaryocytes Br J Haematol. 1998 Jun; 101(3): 420-424.

18. Hans Wadenvik, Dick Stockelberg, Ming Hou. Platelet proteins as autoantibody targets in idiopathic thrombocytopenic purpura. Acta Paediatr Suppl. 1998 Jun;424:26-36.

19. Ming Hou, Jan Carneskog, Ulf-Henrik Mellqvist, Dick Stockelberg, Martin Hedberg, Hans Wadenvik and Jack Kutti. Impact of endogenous thrombopoietin levels on the differential diagnosis of essential thrombocythaemia and reactive thrombocytosis. Eur J Haematol, 1998 Aug;61(2):119-22.

20. Stockelberg D, Jonson T, Hansson E. Long term follow up of of patients with deep vein thrombosis treated in an outpatient setting. Journal of Thrombosis and Thrombolysis. 1998: 6: 169-171

21. Antikoagulantiasköterska-en ny subspecialitet? D. Stockelberg, L. Stigendal, H. Ericsson. Läkartidningen. 1999: 96: 10: 1205-1207

22. Ericsson H, Eriksson UG, Frison L, Hansson PO, Held P, Holmstöm M, Hägg A, Jonsson T, Lapidus L, Leijd B, Stockelberg D, Säfwenberg U, Taghavi A,Thorsen M. Pharmacokinetics and pharmacodynamics of melagatran, a novel synthetic low molecular weight thrombin inhibitor, in patients with acute deep vein thrombosis. Thromb Haemost. 1999: 81: 358-363

23. Plasma thrombopoietin levels in liver cirrhosis and kidney failure. Stockelberg D, Andersson P-O, Björnsson E, Björk S, Wadenvik H. J Intern Med. 1999: 246: 5:471-475.

24. Blödningskomplikationer vid antikoagulantiabehandling. Ali Taghavi, Tomas Jonson, Dick Stockelberg. Läkartidningen, Läkartidningen. 1999: 96: 32/33: 3421-3424

25. Andersson P.O., Stockelberg D, Jacobsson S, Wadenvik H. A TGF-β1 mediated bystander immune suppression could be associated with remission of chronic idiopathic thrombocytopenic purpura. Ann Hematol. 2000 Sep;79(9):507-13.

26. Andréasson B, Lindstedt G, Stockelberg D, Wadenvik H, Kutti J. The relation between plasma thrombopoietin and erythropoietin concentrations in polycythemia vera and essential thrombocythemia. Leuk Lymphoma. 2001 May;41(5-6):579-84.

27. Sjöblom L, Hardemark HG, Lindgren A, Norrving B, Fahlen M, Samuelsson M, Stigendal L, Stockelberg D, Taghavi A, Wallrup L, Wallvik J Management and prognostic features of intracerebral hemorrhage during anticoagulant therapy: a Swedish multicenter study. Stroke 2001 Nov;32(11):2567-74

28. Heurgren M, Felt M, Dannberg E, Netzler B, Stockelberg D, Kron B, Sjöli P, Väärt J. Case costing in Sweden, a way to describe, compare and reimburse-an example from haematological care. Casemix, 2002 March 31; 4; 1; 3-10

29. Hallbook H, Simonsson B, Ahlgren T, Bjorkholm M, Carneskog J, Grimfors G, Hast R, Karlsson K, Kimby E, Lerner R, Linder O, Linderholm M, Lofvenberg E, Malm C, Nilsson PG, Paul C, Stenke L, Stockelberg D, Tidefelt U, Turesson I, Uden-Blome AM, Vilen L, Wahlin A, Winquist I, Smedmyr B. High-dose cytarabine in upfront therapy for adult patients with acute lymphoblastic leukaemia. Br J Haematol 2002 Sep;118(3):748-54

30. Wernstedt P, Brune M, Andersson PO, Gustavsson B, Stockelberg D, Wadenvik H. Favorable outcome with STI571 (imatinib mesylate) and allogeneic stem cell transplantation in a case of Ph+ chemorefractory acute lymphocytic leukaemia. Bone Marrow Transplant 2002 Dec;30(12):971-3

31. Bram S, Swolin B, Rodjer S, Stockelberg D, Ogard I, Back H. Is monosomy 5 an uncommon aberration? Fluorescence in situ hybridization reveals translocations and deletions in myelodysplastic syndromes or acute myelocytic leukemia. Cancer Genet Cytogenet 2003 Apr 15;142(2):107-14

32. Hoglund M, Brune M, Sallerfors B, Ahlgren T, Billstrom R, Hedenus M, Markevarn B, Nilsson B, Simonsson B, Stockelberg D, Wahlin A.More efficient mobilisation of peripheral blood stem cells with HiDAC+AMSA+G-CSF than with mini-ICE+G-CSF in patients with AML.Bone Marrow Transplant. 2003 Dec;32(12):1119-24.

33. Stockelberg D, Heurgren M, Sjoli P, Vaart J, Mellqvist UH, Kron B. CPP (Cost Per Patient) is functioning well in the everyday care. The myeloma care program in Vastra Gotaland--an illustrative example. Lakartidningen. 2003 Oct 16;100(42):3316-8.

34. Wennstrom L, Juntikka EL, Safai-Kutti S, Stockelberg D, Holmberg E, Luik E, Everaus H, Palk K, Varik M, Aareleid T, Kutti J. The incidence and survival of acute de novo leukaemias in Estonia and in a well defined region of Western Sweden during 1982-1996: a survey of patients aged 16-64 years. Leuk Lymphoma. 2004 May;45(5):915-21.

35. Luik E, Palk K, Everaus H, Varik M, Aareleid T, Wennstrom L, Juntikka EL, Safai-Kutti S, Stockelberg D, Holmberg E, Kutti J. The incidence and survival of acute de novo leukaemias in Estonia and in a well-defined region of western Sweden during 1982-1996: a survey of patients aged > or =65 years. J Intern Med. 2004 Jul;256(1):79-85.

36. Lofgren C, Paul C, Astrom M, Hast R, Hedenius M, Lerner R, Liliemark J, Nilsson I, Rodjer S, Simonsson B, Stockelberg D, Tidefelt U, Bjorkholm M. Granulocyte-macrophage colony-stimulating factor to increase efficacy of mitoxantrone, etoposide and cytarabine in previously untreated elderly patients with acute myeloid leukaemia: a Swedish multicentre randomized trial. Br J Haematol. 2004 Feb;124(4):474-80.

37. Hardling M, Wei Y, Palmqvist L, Swolin B, Stockelberg D, Gustavsson B, Ekeland-Sjöberg K, Wadenvik H, Ricksten A. Serial monitoring of BCR-ABL transcripts in Chronic Myelougenous leukaemia (CML) treated with Imatinibe Mesylate. Med Oncol. 2004;21(4):349-58.

38. H Hallböök, H Hägglund, D Stockelberg, P-G Nilsson, K Karlsson, M Björkholm, M Linderholm, A Wahlin, O Linder and B Smedmyr for the Swedish Adult ALL Group Autologous and allogeneic stem cell transplantation in adult ALL: the Swedish Adult ALL Group experience Bone Marrow Transplantation (2005) 35, 1141−1148.

39. G Juliusson, R Billström, A Gruber, E Hellström-Lindberg, M Höglund, K Karlsson, D Stockelberg, A Wahlin, M Åström, C Arnesson, U Brunell-Abrahamsson, J Carstensen, E Fredriksson, E Holmberg, K Nordenskjöld and F Wiklund for the Swedish Adult Acute Leukemia Registry Group Attitude towards remission induction for elderly patients with acute myeloid leukemia influences survival Leukemia (2006) 20, 42–47. 21 November 2005

40. Wei Y, Stockelberg D, Hullberg S, Ricksten A, Wadenvik H. Changes in Expression of Apoptosis-Related Genes Are Linked to the Molecular Response to Imatinib Treatment in Chronic-Phase Chronic Myeloid Leukemia Patients. Acta Haematol. 2007;117(2):83-90

41. Wei Y, Hardling M, Olsson B, Hezaveh R, Ricksten A, Stockelberg D, Wadenvik H. Not all imatinib resistance in CML are BCR-ABL kinase domain mutations. Ann Hematol. 2006 Dec;85(12):841-7.

42. Cornely OA, Maertens J, Winston DJ, Perfect J, Ullmann AJ, Walsh TJ, Helfgott D, Holowiecki J, Stockelberg D, Goh YT, Petrini M, Hardalo C, Suresh R, Angulo-Gonzalez D. Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia.
N Engl J Med. 2007 Jan 25;356(4):348-59.

43. Linderholm M, Höglund M, Stockelberg D. Specialist associations\\\' mission: equal and good cancer care for all Lakartidningen. 2008 Jan 30-Feb 5;105(5):306-7.

44. Gunnar Juliusson, Petar Antunovic, Åsa Derolf, Sören Lehmann, Lars Möllgård, Dick Stockelberg, Ulf Tidefelt, Anders Wahlin, Martin Höglund, for the Swedish Acute Myeloid Leukemia Registry Group Age and Acute Myeloid Leukemia. Real World Data on Decision to Treat and Outcomes from the Swedish Acute Leukemia Registry. Blood. 2009 Apr 30;113(18):4179-87. Epub 2008 Nov 13.

45. . Jan-Erik Johansson, Bengt Hasséus, Peter Johansson, Christer Eklöf, David Öhman and Dick Stockelberg. Gut protection by palifermin during autologous haematopoietic stem cell transplantation. Bone Marrow Transplant. 2009 May;43(10):807-11. Epub 2008 Dec 1.

46. Andersson Inger, RN, Ahlberg Karin, RN PhD, Stockelberg Dick, MD PhD, Brune Mats MD PhD, Persson Lars-Olof, PhD. Health-related quality of life in patients undergoing allogeneic stem cell transplantation following reduced intensity conditioning versus myeloablative conditioning. Acta Oncol. 2008;47(2):275-85.

47. Skovbjerg, Susann; Welinder-Olsson, Christina; Kondori, Nahid; Kjellin, Eva; Nowrouzian, Forough; Wold, Agnes; Stockelberg, Dick; Larsson, Peter; Wennerås, Christine Optimization of the Detection of Microbes in Blood from Immunocompromised Patients with Haematological Malignancies, Clin Microbiol Infect. 2009 Jul;15(7):680-3.

48. Andersson I, Ahlberg K, Stockelberg D, Persson LO. Patients\\\' perception of health-related quality of life during the first year after autologous and allogeneic stem cell transplantation. Eur J Cancer Care (Engl). 2010 Mar 23.

49. Palk K, Luik E, Varik M, Viigimaa I, Vaht K, Everaus H, Wennström L, Stockelberg D, Safai-Kutti S, Holmberg E, Kutti J. The incidence and survival of acute de novo leukemias in Estonia and in a well-defined region of western Sweden during 1997-2001: a survey of patients aged 60>or=65 years. Cancer Epidemiol. 2010 Feb;34(1):24-8.
49.The incidence and survival of acute de novo leukemias in Estonia and in a well-defined region of western Sweden during 1997-2001: a survey of patients aged >or=65 years. Palk Katrin, Luik Ene, Varik Mirja, Viigimaa Iige, Vaht Krista, Everaus Hele, Wennström Lovisa, Stockelberg Dick, Safai-Kutti Soodabeh, Holmberg Erik, Kutti Jack. Cancer Epidemiol 2010:34(1):24-8.

50.Patients' perception of health-related quality of life during the first year after autologous and allogeneic stem cell transplantation. Andersson I, Ahlberg K, Stockelberg D, Persson L-O. Eur J Cancer Care (Engl). 2011 May;20(3):368-79

51.Hematopoietic stem cell transplantation rates and long-term survival in acute myeloid and lymphoblastic leukemia: Real-World Population-Based Data From the Swedish Acute Leukemia Registry 1997-2006. Juliusson Gunnar, Karlsson Karin, Lazarevic Vladimir Lj, Wahlin Anders, Brune Mats, Antunovic Petar, Derolf Asa, Hägglund Hans, Karbach Holger, Lehmann Sören, Möllgård Lars, Stockelberg Dick, Hallböök Helene, Höglund Martin; for the Swedish Acute Leukemia Registry Group, the Swedish Acute Myeloid Leukemia Group, the Swedish Adult Acute Lymphoblastic Leukemia Group. Cancer. 2011 Sep 15;117(18):4238-46

52.Continuing high early death rate in acute promyelocytic leukemia: a population-based report from the Swedish Adult Acute Leukemia Registry. Lehmann S, Ravn A, Carlsson L, Antunovic P, Deneberg S, Möllgård L, Rangert Derolf A, Stockelberg D, Tidefelt U, Wahlin A, Wennström L, Höglund M, Juliusson G. Leukemia 2011 Jul;25(7):1128-34

53.The Incidence and Survival of Acute de novo Leukemias in Estonia and in a Well-Defined Region of Western Sweden during 1997-2001: A Survey of Patients Aged 16-64 Years. Wennström Lovisa, Safai-Kutti Soodabeh, Stockelberg Dick, Holmberg Erik, Palk Katrin, Varik Mirja, Viigimaa Iige, Vaht Krista, Luik Ene, Everaus Hele, Kutti Jack. Acta haematologica 2011:126(3):176-185.
54. Sequential population-based studies over 25 years on the incidence and survival of acute de novo leukemias in Estonia and in a well-defined region of western Sweden during 1982-2006: a survey of patients aged ≥65 years. Punab M, Palk K, Varik M, Laane E, Everaus H, Holmberg E, Hulegårdh E, Wennström L, Safai-Kutti S, Stockelberg D, Kutti J. Med Oncol. 2013 Mar;30(1):487. doi: 10.1007/s12032-013-0487-x
55.Decreased survival in normal karyotype AML with single-nucleotide polymorphisms in genes encoding the AraC metabolizing enzymes cytidine deaminase and 5'-nucleotidase. Falk IJ, Fyrberg A, Paul E, Nahi H, Hermanson M, Rosenquist R, Höglund M, Palmqvist L, Stockelberg D, Wei Y, Gréen H, Lotfi K.Am J Hematol. 2013 Jul 22. doi: 10.1002/ajh.23549.

56.Prerequisites required for the provision and use of web-based communication for psychosocial support in haematologic care. Högberg K, Sandman L, Nyström M, Stockelberg D, Broström A. Eur J Oncol Nurs. 2013 Oct;17(5):596-602

57. Swedish. No abstract available. Stockelberg D. Lakartidningen. 2013 Apr 3-16;110(27-28):1295-6.
58.Decreased survival in normal karyotype AML with single-nucleotide polymorphisms in genes encoding the AraC metabolizing enzymes cytidine deaminase and 5'-nucleotidase. Falk IJ, Fyrberg A, Paul E, Nahi H, Hermanson M, Rosenquist R, Höglund M, Palmqvist L, Stockelberg D, Wei Y, Gréen H, Lotfi K. Am J Hematol. 2013 Dec;88(12):1001-6

59.Incidence and prognostic significance of karyotypic subgroups in older patients with acute myeloid leukemia: Experience from the population-based Swedish AML registry. Vladimir Lazarevic,1,2 Ann-Sofi Hörstedt,3 Bertil Johansson,4,5 Petar Antunovic,6 Rolf Billström,7 Åsa Derolf,8 Erik Hulegårdh,9 Sören Lehmann,8 Lars Möllgård,9 Christer Nilsson,8 Stefan Peterson,3 Dick Stockelberg,9 Bertil Uggla,10 Lovisa Vennström,9 Anders Wahlin,11 Martin Höglund,12 and Gunnar Juliusson1,2. Blood Cancer J. 2014 Feb 28;4:e188.
60.The Meaning of Web-Based Communication for Support: From the Patients' Perspective Within a Hematological Healthcare Setting. Högberg KM, Stockelberg D, Sandman L, Broström A, Nyström M. Cancer Nurs. 2014 May 14.
61. Impact of ABCB1 single nucleotide polymorphisms 1236C>T and 2677G>T on overall survival in FLT3 wild-type de novo AML patients with normal karyotype. Jakobsen Falk I, Fyrberg A, Paul E, Nahi H, Hermanson M, Rosenquist R, Höglund M, Palmqvist L, Stockelberg D, Wei Y, Gréen H, Lotfi K. Br J Haematol. 2014 Aug 23. doi: 10.1111/bjh.13097.
62. Characterization and prognostic features of secondary acute myeloid leukemia in a population-based setting: a report from the Swedish Acute Leukemia Registry. Hulegårdh E, Nilsson C, Lazarevic V, Garelius H, Antunovic P, Rangert Derolf Å, Möllgård L, Uggla B, Wennström L, Wahlin A, Höglund M, Juliusson G, Stockelberg D, Lehmann S. Am J Hematol. 2015 Mar;90(3):208-14
63. Failure matters: unsuccessful cytogenetics and unperformed cytogenetics are associated with a poor prognosis in a population-based series of acute myeloid leukaemia. Lazarevic V, Hörstedt AS, Johansson B, Antunovic P, Billström R, Derolf Å, Lehmann S, Möllgård L, Peterson S, Stockelberg D, Uggla B, Vennström L, Wahlin A, Höglund M, Juliusson G. Eur J Haematol. 2015 May;94(5):419-23.
64. Induction with azacytidine followed by allogeneic hematopoietic stem cell transplantation in a Jehovah's Witness with acute monocytic leukemia. Hege Garelius, Sofia Grund and Dick Stockelberg* Clinical Case Reports Volume 3, Issue 5, pages 287–290, May 2015
65. Association between TERT promoter polymorphisms and acute myeloid leukemia risk and prognosis. Mosrati MA, Willander K, Falk IJ, Hermanson M, Höglund M, Stockelberg D, Wei Y, Lotfi K, Söderkvist P. Oncotarget. 2015 Sep 22;6(28):25109-20.

66.Caring Through Web-Based Communication: A Qualitative Evaluation of a Nursing Intervention to Create Holistic Well-Being Among Patients With Hematological Disease.Högberg KM, Sandman L, Nyström M, Stockelberg D, Broström A.J Holist Nurs. 2016 Sep 22.
67.Acute de novo Leukemia in Estonia and Western Sweden 1982-2006: Positive Trend in the Survival of Acute Leukemia over 25 Years. Hulegårdh E, Punab M, Holmberg E, Palk K, Laane E, Everaus H, Wennström L, Stockelberg D. Acta Haematol. 2016;136(3):167-73.

68.Acute Myeloid Leukemia in Adolescents and Young Adults Treated in Pediatric and Adult Departments in the Nordic Countries. Wennström L, Edslev PW, Abrahamsson J, Nørgaard JM, Fløisand Y, Forestier E, Gustafsson G, Heldrup J, Hovi L, Jahnukainen K, Jonsson OG, Lausen B, Palle J, Zeller B, Holmberg E, Juliusson G, Stockelberg D, Hasle H; Nordic Society of Paediatric Haematology and Oncology (NOPHO).; Danish Acute Leukemia Group.; Swedish Acute Myeloid Leukemia Group. Pediatr Blood Cancer. 2016 Jan;63(1):83-92.

Other publications

  1. Abstracts
  2. H Wadenvik, D Stockelberg, J Kutti. Autoantibody specificity and frequency in chronic immune thrombocytopenia (ITP). Poster, International Society of Thrombosis and Hemostasis, New York 1993
  3. D Stockelberg, S Jacobsson, J Kutti, H Wadenvik Evidence for a light chain restriction of glycoprotein Ib/IX and Iib/IIIa reactive autoantibodies in chronic immune thrombocytopenic purpura. Poster, European Association of Hematology, Bryssel 1994
  4. M Hou, H Wadenvik, D Stockelberg, I Andersson, J Kutti. Clinical relevance of anti-glycoprotein autoantibodies in chronic immune thrombocytopenic purpura. Poster, European Association of Hematology, Bryssel, 1994
  5. M Hou, D Stockelberg, J Kutti, H Wadenvik. Identification of platelet cytoskeleton tropomyosin as an autoantigen in chronic thrombocytopenic purpura. Poster, Läkarstämman 1994
  6. D.Stockelberg, S. Jacobsson, M. Hou, B. Swolin, J. Kutti and H. Wadenvik. Are the autoantibodies in chronic immune thrombocytopenia of clonal origin? Poster, American Society of Hematology, Nashville 1994
  7. M Hou, D Stockelberg, J Kutti, H Wadenvik. Identification of platelet cytoskeleton tropomyosin as an autoantigen in chronic thrombocytopenic purpura. Poster, American Society of Hematology, Nashville 1994
  8. D Stockelberg, S Jacobsson, M Hou, B Swolin, J Kutti, H Wadenvik. Är kronisk ITP en klonal sjukdom? Föredrag, Läkarstämman 1994
  9. D Stockelberg, M Hou, J Kutti, H Wadenvik. Glycoprotein IIb/IIIa autoantigenic repertoire in chronic idiopathic thrombocytopenic purpura (ITP). Poster, American Society of Hematology, Seattle 1995
  10. D Stockelberg, M Hou, J Kutti, H Wadenvik. Glycoprotein Ia/IIa, Ib/IX, IIb/IIIa och IV reaktiva autoantikroppar vid kronisk immunologisk tronbocytopen purpura. Poster, Nordiskt hematologiskt vårmöte, Tromsö 1995
  11. T Jonsson, I Andersson, B Rydström, D Stockelberg. Poliklinisk trombosbehandling. Poster, Läkarstämman 1995
  12. D.Stockelberg, S.Jacobsson, J.Kutti, och H.Wadenvik. Är autoantikropparna vid kronisk immunologisk trombocytopeni klonalt begränsade? Poster Nordiskt hematologiskt vårmöte, Uppsala 1996
  13. D Stockelberg, L Rydberg, J Kutti, H Wadenvik. Evidence for an expression of blood group A antigen on platelet glycoprotein IV and V. M Hou, Poster, 4:th European syposium on platelet and granulocyte immunobiology, Hämeenlinna 1996
  14. Abstracts
  15. H Wadenvik, M Hou, E Horney, C Lagerstedt, S Jacobsson, D Stockelberg, J Kutti. Multiple quinine-dependent antibodies in a man with thrombocytopenia, lymphopenia, neutropenia and granulomatous hepatitis. Poster, 4:th European syposium on platelet and granulocyte immunobiology, Hämeenlinna 1996
  16. D Stockelberg, T Jonsson. Treatment of deep vein thrombosis in an outpatient setting.
  17. Poster, European Association of Hematology, Paris 1996
  18. M Hou, D Stockelberg, L Rydberg, J Kutti, H Wadenvik. Evidence for an expression of blood group A antigen on platelet glycoprotein IV and V. Poster, European Association of Hematology, Paris 1996
  19. H Wadenvik, M Hou, E Horney, C Lagerstedt, S Jacobsson, D Stockelberg, J Kutti. Multiple quinine-dependent antibodies in a man with thrombocytopenia, lymphopenia, neutropenia and granulomatous hepatitis. Poster, European Association of Hematology, Paris 1996
  20. I Norén, P Lethola, D. Stockelberg. Palliativ behandling i hemmet av patienter med hematologisk sjukdomPoster, Nordiskt Hematologiskt Vårmöte, Helsingfors 1996
  21. D Stockelberg, T Jonsson, E Hansson. Long term follow up of patients with deep vein thrombosis treated in an outpatient setting. Poster, International Society of Thrombosis and Hemostasis, Florence 1997
  22. PO Andersson, D Stockelberg, M Hou, H Wadenvik. Det differentialdiagnostiska värdet av thrombopoietinbestämningar vid trombocytopeni. Föredrag, Läkarstämman 1997
  23. D Stockelberg, M Hou, H Wadenvik.Glycoprotein Ia/IIa, Ib/IX, IIb/IIIa, IV and V reactive antibodies in chronic idiopathic thrombocytopenic purpura. Poster, American Society of Hematology, San Diego 1997
  24. H Wadenvik, M Hou, D Stockelberg. The usefulness of plasma thrombopoietin in the differential diagnosis of thrombocytopenic states. Poster, American Society of Hematology, San Diego 1997
  25. D Stockelberg, M Hou, H Wadenvik Heavy-chain and light-chain phenotype compositions of glycoprotein-specific IgG antibodies in chronic idiopathic thrombocytopenic purpura (ITP).
  26. Föredrag, 5:th European syposium on platelet and granulocyte immunobiology, Barcelona 1998
  27. A Olsson, D Stockelberg, PO Andersson, J Kutti, H Wadenvik. Plasma thrombopoietin levels in patients with liver cirrhosis and in patients with end- stage renal failure. Poster, European Association of Hematology, Amsterdam 1998
  28. D Stockelberg, M Hou, H Wadenvik. Heavy-chain and light-chain phenotype compositions of glycoprotein-specific IgG antibodies in chronic idiopathic thrombocytopenic purpura (ITP). Poster, European Association of Hematology, Amsterdam 1998
  29. Abstracts
  30. PO Andersson, M Hou, D Stockelberg, J Kutti, H Wadenvik. Plasma thrombopoietin levels in thrombocytopenic/thrombocythemic states-diagnostic value. Poster, European Association of Hematology, Amsterdam 1998
  31. D Stockelberg. Poliklinisk trombosbehandling. Inbjuden föreläsare, Symposium, Fragmin 10-års jubileum, Stockholm 1998
  32. D Stockelberg, P Moldin, H Wadenvik, Trombocytopeni hos nyfödda. Föredrag, läkarstämman 1998
  33. M Kecskes, D Stockelberg, L Grip, J Kutti, H Wadenvik. Rheopro induced severe thrombocytopenia. Poster, American Society of Hematology, Miami 1998
  34. L Sjöblom, H_G Hårdemark, M Fahle´n, A.Lindgren, M Samuelsson, B Norrving, L Stigendal, D Stockelberg, A Taghavi, L Wallrup, J Wallvik. Treatment of anticoagulant related intracerebral hemorrhage in Seweden 1993-1996. Poster Köpenhamn 1999
  35. P Johansson, T Ekman, B Ridell, D Stockelber. Bilateral trephine biopsy in the diagnosis of lymphoma. Unilateral biopsy enough. Poster EHA, Barcelona 1999
  36. M Höglund, M Brune, B Sallerfors, R Billström, B Markevärn, B Simonsson, D Stockelberg, A Wahlin. Högdos Cytosar+Amekrin+G-Csf ger god mobilisering av perifera stamceller hos patienter med akut myeloisk leukemi. Föredrag, Läkarstämman, Göteborg 2000
  37. P.O. Andersson, A. Olsson, D Stockelberg, H Wadenvik. Reduced mononuclear cells TGF-ß1 production in patients with active ITP indicating a downregulated TH3-response. Föredrag ASH 2000
  38. Tran D, Brune M, Stockelberg D. Uppföljning av allogent och autologt stamcells-transplanterade patienter med akut leukemi under perioden 1990-1999. Föredrag, Läkarstämman, Göteborg 2000
  39. Heurgren M, Felt M, Dannberg E, Kron B, Netzler B, Sjöli P, Stockelberg D, Väärt J. Case Costing in Sweden, a way to describe, compare and reimburse-an example from Haematological care. 17:th Internatoional Working Conference on Patient Classification System/Europe (PCS/E). Poster Brugge 2001
  40. Bram S, Rodjer S, Stockelberg D, Ogard I, Back H , Swolin B. FISH applied on chromosome 5 abberations in patients with MDS and AML. Poster MDS Stockholm 2001
  41. Reduced intensity conditioning (RIC) and allografting in Waldenström´s macroglobulinemia. A case report Pernilla Wernstedt, Dick Stockelberg, Jan-Erik Johansson, Mats Brune. Poster ASH 2002.
  42. C. Löfgren, C. Pau, M. Åström, R. Has, M. Hedenius, R. Lerne, J. Liliemark, I. Nilsson, S. Rödjer, B. Simonsson D. Stockelberg, U. Tidefelt and M. Björkholm Granulocyte-macrophage colony-stimulating factor to increase efficacy of mitoxantrone, etoposide and cytarabine in previously untreated elderly patients with acute myeloid leukaemia: a Swedish multicentre randomized. Poster NHSM, Linköping 2002.
  43. Ricksten A, Palmqvist L,, Swolin B, Hardling M, Stockelberg D, Gustavsson B, Wadenvik H. Quantitative rt-PCR for measurement of BCR/ABL transcripts in chronic myelogenous leukemia (CML) treated with STI571. Poster EHA, Florense Italy 2002
  44. H Hallböök, H. Hägglun, K .Karlsson. O.Linder, M.Linderholm, P.G. Nilsson, D.Stockelberg, I.Turesson, A.Wahlin, B.Smedmyr. The Swedish Adult ALL Group. Autologus and allogeneic stem cell transplantation (SCT) for high-risk adult acute lymphoblastic leukemia-a national experience. Poster EHA, Lyon 2003
  45. Gunnar Juliusson, Rolf Billstrom, Astrid Gruber, Eva Hellstrom-Lindberg, Martin Hoglund, Karin Karlsson, Dick Stockelberg, Anders Wahlin, Maria Astrom Secondary Acute Leukemia in Sweden 1997-2001: Strong Prognostic Influence Only in Patients Less Than 70 Years. Abstract 4683 ASH, San Diego 2003
  46. G Juliusson, R Billström, A Gruber, E Hellström-Lindberg, M Höglund, K Karlsson, D Stockelberg, A Wahlin, M Åström, C Arnesson, E Holmberg, K Nordenskjöld, J Carstensen.. Attitude towards remission induction (RI) for elderly patients with acute myeloid leukemia (AML) and survival. Analysis from the Swedisk adult acute leukaemia registry. Abstract 098 EHA, Geneva 2004 The Hematology Journal (2004) 5, S30-S38

Work experience

WorkplaceDegree of EmploymentStartedEnded
Landsting - Västra Götalandsregionen - Specialiserad vård - Södra Älvsborgs sjukhus (SÄS) workplace verified by Västra Götalandsregionen on 2018-02-27
75% 2018
Landsting - Västra Götalandsregionen - Specialiserad vård - Södra Älvsborgs sjukhus (SÄS) workplace verified by Västra Götalandsregionen on 2018-02-27 Show info
Överläkare


Verksamhetschef medicinkliniken

100% 2015 2017
Landsting - Västra Götalandsregionen - Specialiserad vård - Södra Älvsborgs sjukhus (SÄS) workplace verified by Västra Götalandsregionen on 2018-02-27 Show info
Överläkare


Verksamhetschef medicinkliniken

50% 2014 2015
Landsting - Övergripande Sveriges Kommuner och Landsting Show info
Medicinsk chef Inera AB

50% 2012 2015
Landsting - Västra Götalandsregionen - Specialiserad vård - Sahlgrenska Universitetssjukhuset - Område 6 - Medicin, Sahlgrenska workplace verified by Västra Götalandsregionen on 2018-02-27 Show info
Överläkare, Sektionen för hematologi och koagulation









Medicinområdet, SU/Sahlgrenska 981101-ff









Sektionschef,Sektionen för hematologi och koagulationMedicinområdet, SU/Sahlgrenska 000901-081201








Verksamhetschef Medicin, Sahlgrenska 080901-110901

100% 1998 2014
Landsting - Västra Götalandsregionen - Specialiserad vård - NU-sjukvården Uddevalla sjukhus workplace verified by Västra Götalandsregionen on 2018-02-27 Show info
Sektionschef hematologisektionen/medicinkliniken
NU-sjukvården9711-9810

100% 1997 1998
Landsting - Västra Götalandsregionen - Specialiserad vård - Södra Älvsborgs sjukhus (SÄS) workplace verified by Västra Götalandsregionen on 2018-02-27 Show info
Överläkare medicinkliniken Borås las 1993-1997

Specialitetsansvarig hematologi/koagulation 1994-1997

100% 1993 1997
Landsting - Västra Götalandsregionen - Specialiserad vård - Sahlgrenska Universitetssjukhuset - Område 6 - Medicin, Sahlgrenska workplace verified by Västra Götalandsregionen on 2018-02-27 Show info
Underläkare hematologisektionen
Sahlgrenska sjukhuset 1991-1992

100% 1991 1992
Landsting - Västra Götalandsregionen - Specialiserad vård - Södra Älvsborgs sjukhus (SÄS) workplace verified by Västra Götalandsregionen on 2018-02-27 Show info
AT-läkare Borås las 1986-1988
FV-läkare internmed Borås lasarett 1988-1990

100% 1986 1990
Övrigt - Övrigt Show info
Bitr sjukhemsförest
Treklöverhemmet 1980-1981

100% 1980 1981
Landsting - Västra Götalandsregionen - Specialiserad vård - NU-sjukvården Uddevalla sjukhus workplace verified by Västra Götalandsregionen on 2018-02-27 Show info
Sjuksköterska hjärtavd
Uddevalla las 1977-1979

100% 1977 1979
Kommun - Enskilda kommuner - Mölndal Show info
Undersköterska Fässbergshemmet1974-1975

100% 1974 1975

Föreläsning X:th symposium on platelet and granulocyte immunobiolgy; Sapin 1997.

Startat utbildning för sjuksköterskor/BMA som arbete med antikoagulantia 1996. Kursen går fortfarande och är den enda i sitt slag i landet. Var kursledare fram till 2001.
Sedvanlig undervisning för kandiadter varje termin
Inbjuden föreläsare till Estlands XBalthic hematology conference)
Inbjuden föreläsare till Jinan University i China 1996 och 2004.
Föreläsare på onkologikursen för sjuksköterskor sedan 5 år tillbaka
Föreläsningar för personalen på sektionen 1-2 ggr/termin

Yrkesverksamhet:
Undersköterska Fässbergshemmet1974-1975
Sjuksköterska hjärtavd
Uddevalla las 1977-1979
Bitr sjukhemsförest
Treklöverhemmet 1980-1981
AT-läkare Borås las1986-1988
FV-läkare internmed
Borås lasarett 1988-1990
Underläkare hematologisektionen
Sahlgrenska sjukhuset 1991-1992
Överläkare medicinkliniken
Borås las 1993-1997
Specialitetsansvarig hematologi/koagulation 1994-1997
Sektionschef hematologisektionen/medicinkliniken
NU-sjukvården9711-9810

Överläkare, Sektionen för hematologi och koagulation
Medicinområdet, SU/Sahlgrenska 981101-140731

Sektionschef,Sektionen för hematologi och koagulationMedicinområdet, SU/Sahlgrenska 000901-091201

Verksamhetschef VO Medicin, SU/Sahlgrenska 091201-110901

Överläkare medonk kliniken SÄS 2014-08-01
tf Verksamhetschef medonk SÄS

Övriga meriter:
Styrelseledamot Svensk förening för hematologi 2001-2007
Stipendieansvarig Svensk förening för hematologi 2001 ff
Ordförande Svensk förening för hematologi 2004-2006
Ordförande Nordisk förening för hematologi 2005-2006
Gästprofessor Shandong University, China 2004

Information is reliable | confirmed 2017-05-29 by Dick Stockelberg |

User account for Dick Stockelberg, from FoU i Sverige
http://www.researchweb.org/is/sverige/user/html/1681